Skip to content

In the BioHarmony Drug Report Database

Vinflunine

Javlor (vinflunine) is a small molecule pharmaceutical. Vinflunine was first approved as Javlor on 2009-09-21. It has been approved in Europe to treat transitional cell carcinoma and urologic neoplasms.
Trade Name Javlor
Common Name Vinflunine
Indication transitional cell carcinoma, urologic neoplasms
Drug Class Vinca alkaloids
Vinflunine
Get full access now